Aquestive Therapeutics Inc (AQST)
$3.89 -3.71% Close Oct 30, 2026 Live
Aquestive Therapeutics stock today
Aquestive Therapeutics closed at $3.89 on October 30, 2026, down 3.71% on the day. Over the past year it returned -41.6% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $488 million.
$4.00$6.00
NovJan 2026MarMayJulSep
| Period | AQST | S&P 500 (SPY) |
|---|---|---|
| 1 month | -16.0% | -0.9% |
| 3 months | +4.6% | +2.1% |
| Year to date | -39.8% | +11.7% |
| 1 year | -41.6% | +12.4% |
| 3 years | +157.6% | +88.5% |
| 5 years | -24.3% | +76.0% |
Key statistics
- Market value
- $488M
- Price / sales
- 9.0
- 52-week range
- $2.95 to $6.82
- Next report
- Nov 3, 2026
About Aquestive Therapeutics
Aquestive Therapeutics develops specialty pharmaceutical products using proprietary oral delivery technologies.
Sector: Health Care
More on Aquestive Therapeutics
- Financials: revenue, earnings and segmentsRevenue -23% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $756.81 today
No forecast, no recommendation. This page describes Aquestive Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.